Jess Rohmann Profile picture
PhD, She/her | Neuroepidemiology, improving science & improv comedy @iphberlin @chariteberlin @bemcolloquium https://t.co/6FAUzaJcCu
Mar 16, 2021 22 tweets 6 min read
New @PEI_Germany report provides much needed clarity to the #AstraZeneca "pause" in Germany. Not yet available in English. I will try to summarize. /thread pei.de/SharedDocs/Dow… As of Monday (March 15th), 2021, 7 cases of specific form of severe cerebral venous thrombosis associated with platelet deficiency (thrombocytopenia) were identified. The individuals were 20-50 years old and 3 of them subsequently died. /2
Mar 15, 2021 4 tweets 2 min read
Hey @PEI_Germany: can you please share the numbers? Truly a #scicomm nightmare. If Germany's entire #AstraZeneca based vaccination strategy is going down the pipes, please give us a transparent "why". Comes across as very cryptic and fuels conspiracy theory fires. I'm so tired. Announced first in late evening talk/news shows:
Nov 6, 2019 36 tweets 23 min read
Now @BEMColloquium , @shell_ki begins her talk on life course epidemiology, focusing on inequalities in health @BEMColloquium @shell_ki The socioeconomic gradient in health
Jun 18, 2019 31 tweets 7 min read
Done with G and ready for E! I'll try to tweet a bit more this talk. My fingers were too busy coding this morning... #SER2019 Starting off with a brief history of sensitivity analyses, bounds for effects and the cornfield conditions (how strong associations between U and A, later U and Y) would have to be to completely explain away the observed RR relating A any Y)